Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season
Completed · Not applicable
Conditions studied: Influenza, COVID-19, Vaccination Hesitancy
In brief
This multi-site study assesses the impact of text message reminders on the receipt of COVID-19 and influenza text message reminders takes place primarily in practices from the American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) network.
Key facts
- Study ID
- NCT06603090
- Run by
- Columbia University
- People needed
- 66147
- Starts
- 2024-10-02
- Expected to finish
- 2025-04-30
- Last updated by the study team
- 2025-07-11
Who can join
Age: 1 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Child that:
- is 6 months-17 year-old children
- due for both a COVID-19 and influenza vaccine
- Receives care at study site
- Language listed in electronic health record is English or Spanish
- Has not opted out of text messages from practice
You may not qualify if…
- Has opted out of text messages from practice
- Language listed in electronic health record is not English or Spanish
Where it is running
- American Academy of Pediatrics — Itasca, Illinois, United States
- Columbia University Irving Medical Center — New York, New York, United States
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.